Tariq Muzzafar, MBBS

Tariq Muzzafar practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Tariq Muzzafar's NPI, 1891704094, was assigned on August 5, 2006. Tariq Muzzafar graduated from Government Medical College Srinagar in 1994. Tariq Muzzafar holds California license A 85809.

Tariq Muzzafar's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Tariq Muzzafar's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Tariq Muzzafar is also affiliated with St. David's South Austin Medical Center. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Tariq Muzzafar practices, 2 sites in all. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Tariq Muzzafar's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Tariq Muzzafar is board certified in anatomic pathology & clinical pathology by the American Board of Pathology. Dmand AI has Tariq Muzzafar's licenses on file in 2 states: California and Texas.

CMS data shows 2,206 Medicare services from Tariq Muzzafar across 12 procedure codes in 2024, for 380 Medicare patients. Medicare paid $57,321 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 380 Medicare patients who saw Tariq Muzzafar in 2024. The largest group is 65 to 74, with 198 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 6% are also on Medicaid. Their average risk score is 3.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Tariq Muzzafar's median patient age at 66, with 52% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Tariq Muzzafar for performance year 2024, reported as part of a group. Tariq Muzzafar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 28 papers to Tariq Muzzafar, published from 2013 to 2024. 2021 was the busiest year, with 5. The most frequent topics are Myelodysplastic Syndromes, Antineoplastic Combined Chemotherapy Protocols and Biomarkers, Tumor. Tariq Muzzafar has published most often in Leuk Lymphoma. Tariq Muzzafar's most frequent co-authors are Leonard Jeffrey Medeiros, MD, Sa A. Wang, MD and Guilin Tang, MD.

CMS Open Payments shows 1 general payment to Tariq Muzzafar from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $98.

Tariq Muzzafar graduated from Government Medical College Srinagar in 1994. Tariq Muzzafar is a member of ASH and Society for Hematopathology.

Tariq Muzzafar is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.